
Sanjivani Paranteral Ltd. (SANJIVIN): Sanjivani Paranteral Share Price Rises 9.74% to Rs 200
Updated: 31 Aug 2026 • 12:21 pm
Posted by:

Sanjivani Paranteral Share Price rose to Rs 200 from Rs 182.25, up 9.74% today. The company’s market capitalisation stands at Rs 223.88 crore, and the supplied data confirms a sharp price rise without establishing a company-specific catalyst.
Sanjivani Paranteral Share Price moved higher in today’s trade, with the stock closing at Rs 200 against the previous close of Rs 182.25. That is a day gain of Rs 17.75, or 9.74%, while the market capitalisation is Rs 223.88 crore. The move places Sanjivani Paranteral Ltd. in today’s Stock Market Today discussion and makes the name relevant in Stocks in News and Top Gainers Today screens. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Sanjivani Paranteral Share Price Today, the key next checks are valuation, sector comparison and any future company disclosures that can explain the move. Univest is using only verified data here to keep the read factual and current.
Sanjivani Paranteral Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 200 |
| Previous Close | Rs 182.25 |
| Today's Move | Rs 17.75 (+9.74%) |
| Open | Rs 185.95 |
| High | Rs 203.5 |
| Low | Rs 177.25 |
| Turnover | Rs 1.19 crore |
| Market Capitalisation | Rs 223.88 crore |
| Market Cap Category | Micro Cap |
Sanjivani Paranteral Ltd. (SANJIVIN) rose to Rs 200 from the previous close of Rs 182.25, a move of Rs 17.75 or 9.74%. The stock opened at Rs 185.95, reached a high of Rs 203.5, recorded a low of Rs 177.25.
The Sanjivani Paranteral Share Price rose from Rs 182.25 to Rs 200 today. The stock opened at Rs 185.95, touched an intraday high of Rs 203.5 and a low of Rs 177.25, and ended above the previous close with a Rs 17.75 gain. Turnover stood at Rs 1.19 crore. These figures show the day’s price action clearly, while the supplied data does not establish why the move occurred. In plain terms, Sanjivani Paranteral Share Price Today reflects a higher closing level within the day’s range and a meaningful change in market value for the session. For Sanjivani Paranteral Stock News readers, the useful point is the verified move itself, not an unconfirmed cause. Univest is keeping the analysis grounded in the numbers available.
Sanjivani Paranteral Ltd. (SANJIVIN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 223.88 crore |
| P/E Ratio | 29.98x |
| P/B Ratio | 4.41x |
| ROE | 25.9% |
| ROCE | 29.18% |
| EPS | Rs 6.08 |
| Book Value Per Share | Rs 41.3 |
| Dividend Yield | 0% |
Sanjivani Paranteral Ltd. (SANJIVIN) fundamental metrics show P/E 29.98x, P/B 4.41x, ROE 25.9%, ROCE 29.18%. These figures provide context only and are not a buy or sell signal.
Sanjivani Paranteral Ltd. has a market capitalisation of Rs 223.88 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 29.98x, P/B at 4.41x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.9% and ROCE of 29.18%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 6.08, book value per share of Rs 41.3, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.21x, median ROE of 11.78%, median ROCE of 13.6%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.98x |
| Benchmark Median P/E | 31.21x |
| Benchmark Average P/E | 48.1x |
| Benchmark P/E Range | 3.7x to 672.45x |
| Company P/B Ratio | 4.41x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 25.9% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 29.18% |
| Benchmark Median ROCE | 13.6% |
| Company Market Capitalisation | Rs 223.88 crore |
| Benchmark Median Market Cap | Rs 670.73 crore |
Sanjivani Paranteral Ltd. (SANJIVIN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Sanjivani Paranteral Ltd. (SANJIVIN) has a P/E ratio of 29.98x, which is below the benchmark median of 31.21x, a difference of -3.94%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sanjivani Paranteral Ltd. (SANJIVIN) has a ROE of 25.9%, which is above the benchmark median of 11.78%, a difference of +119.86%. Sanjivani Paranteral Ltd. (SANJIVIN) has a ROCE of 29.18%, which is above the benchmark median of 13.6%, a difference of +114.56%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,60,696.31 | 38.09 | 5.33 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,062.83 | 84.12 | 13.93 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,91,515.22 | 87.81 | 21.34 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,18,403.7 | 26.24 | 4.39 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.99 | 3.26 | 11.83 | 16 |
Sanjivani Paranteral Ltd. (SANJIVIN) has a P/E ratio of 29.98x compared with the displayed peer median of 38.09x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 25.9% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 29.18% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Sanjivani Paranteral Ltd. (SANJIVIN) has a market capitalisation of Rs 223.88 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Sanjivani Paranteral
- Sanjivani Paranteral Share Price rose 9.74% today to Rs 200 from Rs 182.25.
- The day’s range was Rs 177.25 to Rs 203.5, with turnover of Rs 1.19 crore.
- Market capitalisation is Rs 223.88 crore, below the same-industry median of Rs 670.73 crore.
- P/E is 29.98 and P/B is 4.41, both measurable against the healthcare benchmark.
- ROE of 25.9 and ROCE of 29.18 are above the same-industry median levels in the supplied data.
About Sanjivani Paranteral
Sanjivani Paranteral Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the company through its listed market context, but does not provide a detailed segment breakdown or product mix. What can be stated confidently is that the business sits within a sector where valuation, profitability and capital efficiency are often compared closely across listed companies. For readers following Sanjivani Paranteral Company News or Sanjivani Paranteral Latest News, the most useful starting points are the company’s market capitalisation, return ratios and peer comparisons, because those are the verified facts available in this dataset. Univest is presenting the company profile in a factual way so the Sanjivani Paranteral Share Price move can be read alongside its broader listed-market identity.
Track Sanjivani Paranteral Share Price on Univest
Use Sanjivani Paranteral Ltd. (SANJIVIN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Sanjivani Paranteral Share Price Live on Univest along with the company’s valuation ratios, market cap, shareholding pattern, 52-week levels and market insights. Univest also helps readers review the stock’s fundamentals, sector comparison and daily share price update in one place. For anyone monitoring Sanjivani Paranteral Share Price Today, that combination makes it easier to follow the stock’s latest market context without relying on fragmented sources.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Sanjivani Paranteral Share Price rise today?
Ans. The supplied data confirms that Sanjivani Paranteral Share Price rose 9.74% to Rs 200, but it does not establish a company-specific catalyst. The session’s move is verified through price, open, high, low and turnover data.
What is Sanjivani Paranteral Share Price today?
Ans. Sanjivani Paranteral Share Price today is Rs 200. It finished above the previous close of Rs 182.25, adding Rs 17.75 during the session and placing the stock among the day’s notable gainers in the available data.
What is the market cap of Sanjivani Paranteral?
Ans. Sanjivani Paranteral’s market capitalisation is Rs 223.88 crore. That places it below the same-industry median of Rs 670.73 crore in the supplied benchmark, which is useful context for size comparison.
How does Sanjivani Paranteral compare with its healthcare peers?
Ans. In the supplied peer set, Sanjivani Paranteral has a smaller market cap than Sun Pharma, Divi’s, Torrent, Zydus and Cipla. Its ROE and ROCE are stronger than most of the listed peers.
What do Sanjivani Paranteral valuation ratios show?
Ans. The stock’s P/E is 29.98 and P/B is 4.41. Against the same-industry median, P/E is slightly lower and P/B is higher, while ROE and ROCE both stand above benchmark levels.
Does Sanjivani Paranteral pay a dividend?
Ans. The supplied dividend yield is 0. That means the current data set does not show a dividend payout yield, so the stock’s reported context comes mainly from earnings and return ratios.
What are the key fundamentals for Sanjivani Paranteral?
Ans. Key supplied fundamentals include EPS of 6.08, book value of 41.3, ROE of 25.9 and ROCE of 29.18. These figures help explain the stock’s earnings, accounting value and capital efficiency backdrop.
Where can I track Sanjivani Paranteral Share Price?
Ans. You can track Sanjivani Paranteral Share Price on Univest for live price context, valuation ratios, shareholding pattern, 52-week levels and market insights. The platform keeps the company’s listed-market data in one place.
Recent Articles

G V ELECTRICALS (GVELECTRIC) Share Price Falls 8.17% Today to Rs 122.50
31 August 2026

Glenmark Pharmaceuticals (GLENMARK) Share Price falls 2.01% as stock trades at Rs 2,466.90
31 August 2026

URBAN COMPANY LIMITED (URBANCO): Urban Company Share Price rises 2.61% as URBANCO gains today
31 August 2026

AMI Organics (ACUTAAS) Share Price Falls 2.08%: ACUTAAS Ends at Rs 3,213.75
31 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
G V ELECTRICALS (GVELECTRIC) Share Price Falls 8.17% Today to Rs 122.50
Glenmark Pharmaceuticals (GLENMARK) Share Price falls 2.01% as stock trades at Rs 2,466.90
URBAN COMPANY LIMITED (URBANCO): Urban Company Share Price rises 2.61% as URBANCO gains today
AMI Organics (ACUTAAS) Share Price Falls 2.08%: ACUTAAS Ends at Rs 3,213.75
CreditAccess Grameen (CREDITACC) Share Price Falls 2.12% to Rs 1,360.70
Popular this week
Sansera Engineering Ltd. (SANSERA): Sansera Engineering Share Price Rises 2.51% to Rs 3,956.75

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





